-
Alopexx completes first-in-man trial of its novel, broad-spectrum anti-microbial vaccine
biospectrumasia
October 27, 2017
Potential to prevent wide range of infections including those caused by antibiotic-resistant organisms.
-
Defining standards & measures for AMR is the need of the hour
biospectrumasia
October 18, 2017
According to one of the report issued by some of the stakeholders last year, antibiotic industry or ingredient manufacturers were responsible for an estimated amount of 30,000-70,000 tons of anti-microbial active waste.
-
More to be Done by Indian government to cope with rising sale of unapproved antibiotics
worldpharmanews
October 11, 2017
In India, the sale of antibiotics requiring the tightest control and regulation is rising the fastest, according to an analysis by researchers at Queen Mary University of London (QMUL) and Newcastle University.
-
Antibiotic development is inadequate to meet global resistance threat, WHO warns
pharmafile
September 21, 2017
WHO has released a report indicating that worldwide development of new antibiotics is not keeping pace with the rising prevalence of antimicrobial resistance, with the risk that we may face an inability to meet growing demand.
-
UK collaboration presents promising data in the fight against antibiotic resistance
pharmafile
September 14, 2017
The collaborative efforts of Domainex and Auspherix have made new progress in the development of a solution to the growing threat of antibiotic resistance.
-
Wockhardt bags US FDA approval for antibiotic injection
expressbpd
August 08, 2017
Oxacillin, a penicillinase-resistant beta-lactam antibiotic, will be launched in the US soon
-
C difficile infections market to hit $1.7bn by 2026
europeanpharmaceuticalreview
July 28, 2017
GlobalData latest report states that the major drivers of this growth include the projected launch of prophylactic options for the prevention of Clostridium difficile infections…
-
Researchers boost existing antibiotic to tackle drug resistance
pharmafile
July 05, 2017
The growing issue of antibiotic resistance is finding itself increasingly central in pharma’s priorities, though many still argue that the problem is not given enough attention.
-
Antibiotic from bacteria found on Kenyan ant could help beat MRSA
europeanpharmaceuticalreview
June 27, 2017
A new antibiotic, produced by bacteria found on a species of African ant, is very potent against antibiotic-resistant ‘superbugs’ like MRSA according to scientists.
-
Antibiotic therapy for nearly 1 in 4 adults with pneumonia does not work
europeanpharmaceuticalreview
May 26, 2017
Approximately one in four (22.1%) adults prescribed an antibiotic in an outpatient setting (such as a doctor’s office) for community-acquired pneumonia does not respond to treatment, according to a new study.